Transdermal delivery of Minoxidil using HA-PLGA nanoparticles for the treatment in alopecia
Source abstract
Abstract
Abstract Background Alopecia has become a very common disease that many people around the world are suffered. Minoxidil (MXD) is the most well-known commercialized drug in its treatment. However, in the case of MXD administration, there are some problems with low efficiency of transdermal delivery and additional side effects. Method MXD and Rhodamine B (Rho B) are encapsulated in poly(Lactide-co-Glycolide) grafted hyaluronate nanoparticles (HA-PLGA/MXD NPs, HA-PLGA/Rho B NPs) which is prepared with W/O/W solvent evaporation method. After then, the investigation is carried out to confirm the feasibility of NPs in alopecia treatment. Results Both of HA-PLGA/MXD NPs and HA-PLGA/Rho B NPs are successfully prepared. In addition, it is confirmed that HA-PLGA NPs sufficiently delivered to cells without any significant cytotoxicity by cell viability, cellular uptake and skin permeation test. Conclusion Taken together, HA-PLGA NPs as a transdermal delivery carrier to hair follicle cells can be exploited to develop the efficient and effective platform of transdermal drug delivery for the treatment of various diseases.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Hair Growth and Disorders · Advancements in Transdermal Drug Delivery · Dyeing and Modifying Textile Fibers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Organic Materials Science and Engineering, College of Engineering, Pusan National University, 2 Busandaehak-ro 63 beon-gil, Geumjeong-gu, Busan 46241, Republic of Korea.
Department of Biomaterials Science, Life and Industry Convergence Institute, Pusan National University, 1268-50 Samrangjin-ro, Miryang 50463, Republic of Korea.
Department of Optic-Mechatronics Engineering, College of Nanoscience and Nanotechnology, Pusan National University, 2 Busandaehak-ro 63 beon-gil, Geumjeong-gu, Busan 46241, Republic of Korea.
Funding
National Research Foundation of Korea · Pusan National University
References (24)
Show source-provided references
1. Messenger AG Rundegren JR. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150:186–94.10.1111/j.1365-2133.2004.05785.x ↗
2. Pratt CH King LE Messenger AG Christiano AM Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3:17011.10.1038/nrdp.2017.11 ↗
3. Yang G Chen Q Wen D Chen Z Wang J Chen G Wang Z Zhang Y Hu J Zhang L Gu Z. A therapeutic microneedle patch made from hair-derived keratin for promoting hair regrowth. ACS Nano. 2019;13:4354–60.10.1021/acsnano.8b09573 ↗
4. Lee HJ Oh DW Na MJ Kim DW Yuk DY Choi HC Lee YB Han K Park CW. Preparation and in vivo evaluation of lecithin-based microparticles for topical delivery of minoxidil. Arch Pharm Res. 2017;40:943–51.10.1007/s12272-017-0934-x ↗
5. Jimenez MG Valganon JA Calle E Casado J. Aromatic C-nitrosation of bioactive molecule. Nitrosation of minoxidil. Org Biomol Chem. 2011;9:7680.10.1039/c1ob05686g ↗
6. Choi NH Shin SY Song SU Sung JH. Minoxidil promotes hair growth through stimulation of growth factor release from adipose-Drived stem cells. Int J Mol Sci. 2018;19:691.10.3390/ijms19030691 ↗
7. Liao AH Lu YJ Lin YC Chen HK Sytwu HK Wang CH. Effectiveness of layer-by-layer microbubbles-based delivery system for applying Minoxidil to enhance hair growth. Theranostics. 2016;6(6):817–27.10.7150/thno.14932 ↗
8. Alkilani AZ McCrudden MT Donnelly RF. Transdermal drug delivery: innovative pharmaceutical Delvelopment based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7:438–70.10.3390/pharmaceutics7040438 ↗
9. Qiang WD Zhou T Lan X Zhang X Guo Y Noman M Du L Li W Lu Y Guan L Zhang L Li X Yang J Li H. A new nanoscale transdermal drug delivery system: oil body-linked oleosin-hEGF improves skin regeneration to accelerate wound healing. J Nanobiotechnol. 2018;16:62.10.1186/s12951-018-0387-5 ↗
10. Svenskaya YI Genina EA Parakhonskiy BV Lengert EV Talnikova EE Terentyuk GS Utz SR Gorin DA Tuchin VV Sukhorukov GB. A simple non-invasive approach toward efficient transdermal drug delivery based on biodegradable particulate system. ACS Appl Mater Interfaces. 2019;11:17270–82.10.1021/acsami.9b04305 ↗
11. Llimkowaska MB Poplawska M Grudzinski IP. Nanocomposites as biomolecules delivery agents in nanomedicine. J Nanobiotechnol. 2019;17:48.10.1186/s12951-019-0479-x ↗
12. Kim KS Kim HM Park YJ Kong WH Lee SW Kwok SJ Hahn SK Yun SH. Noninvasive transdermal vaccination using Hyaluronan Nanocarriers and laser adjuvant. Adv Funct Mater. 2016;26:2512–22.10.1002/adfm.201504879 ↗
13. Huang J Zhang H Yu Y Chen Y Wang D Zhang G Zhou G Liu J Sun Z Sun D Lu Y Zhong Y. Biodegradable self-assembled nanoparticles of poly (D L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer. Biomaterials. 2014;35:550–66.10.1016/j.biomaterials.2013.09.089 ↗
14. Qhattal HS Liu X. Characterization of CD44-mediated Cancer cell uptake and intracellular distribution of Hyaluronan-grafted liposomes. Mol Pharm. 2011;8(4):1233–46.10.1021/mp2000428 ↗
15. Marimuthu M Bennet D Kim SH. Self-assembled nanoparticles of PLGA-conjugated glucosamine as a sustained transdermal drug delivery vehicle. Polym J. 2013;45:202–9.10.1038/pj.2012.103 ↗
16. Naves L Dhand C Almeida L Rajamani L Ramarkrishna S Soares G. Poly(lactic-co-glycolic) acid drug delivery systems through transdermal pathway: an overview. Biomaterials. 2017;6:1–11.10.1007/s40204-017-0063-0 ↗
17. Lee JH Jeong HS Lee DH Beack SE Kim T Lee GH Park WC Kim C Kim KS Hahn SK. Targeted hyaluronate - hollow gold Nanosphere conjugate for anti-obesity Photothermal lipolysis. ACS Biomater Sci Eng. 2017;3:3646–53.10.1021/acsbiomaterials.7b00549 ↗
18. Ansary RH Awang MB Rahman MM. Biodegradable poly(D L-lactide-co-glycolide acid)-based micro/nanoparticles for sustained release of protein drug – a review. Trop J Pharm Res. 2014;13(7):1179–90.10.4314/tjpr.v13i7.24 ↗
19. Rajendran JB Lee SH Park HS. Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications. Biomaterials Res. 2016;20:34.10.1186/s40824-016-0081-3 ↗
20. Park JK Yeom JS Oh EJ Reddy M Kim JT Cho DW Lim HP Kim NS Park SW Shin HI Yang DJ Park KB Hahn SK. Guided bone regeneration by poly(lactic-co-glycolic acid) grafted hyaluronic acid bi-layer films for periodontal barrier applications. Acta Biomater. 2009;5:3394–403.10.1016/j.actbio.2009.05.019 ↗
21. Takeuchi I Hida Y Makino K. Minoxidil-encapsulated poly(L-lactide-co-glycolide) nanoparticles with hair follicle delivery properties prepared using W/O/W solvent evaporation and sonication. Biomed Mater Eng. 2018;29:217–28.10.3233/BME-171724 ↗
22. Chandrasekharan A Hwang YJ Seong KY Park SD Kim SD Yang SY. Acid-treat water-soluble chitosan suitable for microneedle-assisted Intracutaneous drug delivery. Pharmaceutics. 2019;11:209.10.3390/pharmaceutics11050209 ↗
23. Edel S Hongkee S. Recent trends in preparation of poly(lactide-co-glycolide) nanoparticles by mixing polymeric organic solution with Antisolvent. J Nanomaterials. 2015;16:2–22.10.1155/2015/794601 ↗
24. Lee MH Lim HR Lee TH Park JC. Preparation of PLGA microparticles by a double emulsion solvent technique for sustained Elease of (−)-epigallocatechin Gallate (EGCG) and their growth inhibitory effect on rat aortic smooth muscle cells. Biomaterials Res. 2009;13(1):11–5.